sodium (3-(3-methoxy-4-oxidophenyl)acryloyl)((4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)sulfonyl)amide

ID: ALA5283814

Chembl Id: CHEMBL5283814

Max Phase: Preclinical

Molecular Formula: C27H20F3N3Na2O5S

Molecular Weight: 557.55

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C/C(=O)[N-]S(=O)(=O)c2ccc(-n3nc(C(F)(F)F)cc3-c3ccc(C)cc3)cc2)ccc1[O-].[Na+].[Na+]

Standard InChI:  InChI=1S/C27H22F3N3O5S.2Na/c1-17-3-7-19(8-4-17)22-16-25(27(28,29)30)31-33(22)20-9-11-21(12-10-20)39(36,37)32-26(35)14-6-18-5-13-23(34)24(15-18)38-2;;/h3-16H,1-2H3,(H2,32,34,35);;/q;2*+1/p-2

Standard InChI Key:  NMSJRWUGJMSTET-UHFFFAOYSA-L

Associated Targets(Human)

PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRPV1 Tclin Vanilloid receptor (8273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 557.55Molecular Weight (Monoisotopic): 557.1232AlogP: 5.10#Rotatable Bonds: 7
Polar Surface Area: 110.52Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.39CX Basic pKa: CX LogP: 5.90CX LogD: 4.96
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.31Np Likeness Score: -0.78

References

1. Chen W, Xu Q, Ma X, Mo J, Lin G, He G, Chu Z, Li J..  (2023)  Synthesis and biological evaluation of N-(benzene sulfonyl)acetamide derivatives as anti-inflammatory and analgesic agents with COX-2/5-LOX/TRPV1 multifunctional inhibitory activity.,  80  [PMID:36481449] [10.1016/j.bmcl.2022.129101]

Source